One week after President Trump's sons Eric Trump and Donald Trump Jr. rang the opening bell at Nasdaq to announce a $1.5 billion deal involving biotech-to-cryptocurrency payment company Alt5 Sigma Corp. and Trump-backed cryptocurrency firm World Liberty Financial, two top hedge funds have taken positions in the company.
Point72 Asset Management, owned by billionaire Steve Cohen, disclosed on Monday that it has acquired a 4% stake in Alt5 Sigma. The shares are held by a fund under Point72 rather than by Cohen personally. Alt5 Sigma stock plunged 10% on Tuesday to $5.48, valuing Point72's holdings at $26.7 million.
Additionally, another filing released on Monday showed that ExodusPoint Capital Management's main fund purchased approximately 5.9 million shares of Alt5 stock, representing 4.75% of the company. The document revealed that the fund held 6.2 million shares on August 11, accounting for over 5% of outstanding shares, but reduced its position over the following week. ExodusPoint's stake is valued at $32.1 million.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。